Feedback / Questions
trabedersen (OT-101) - Autotelic, Oncotelic
Keytruda (pembrolizumab) - Merck (MSD)
https://www.globenewswire.com/news-release/2022/05/25/2450153/0/en/Oncotelic-Therapeutics-Receives-FDA-Clearance-for-Phase-2-Clinical-Trial-of-OT-101-Pembroluzimab-Combination-for-Mesothelioma-M201.html
May 25, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next